Your browser is no longer supported. Please, upgrade your browser.
ILMN Illumina Inc. monthly Stock Chart
Illumina Inc.
Index- P/E59.77 EPS (ttm)3.27 Insider Own1.00% Shs Outstand144.70M Perf Week-3.21%
Market Cap28.28B Forward P/E47.37 EPS next Y4.13 Insider Trans-32.84% Shs Float143.30M Perf Month-9.46%
Income485.70M PEG2.84 EPS next Q0.83 Inst Own98.00% Short Float2.92% Perf Quarter-7.02%
Sales2.07B P/S13.66 EPS this Y163.30% Inst Trans3.25% Short Ratio2.90 Perf Half Y1.20%
Book/sh12.44 P/B15.71 EPS next Y19.18% ROA14.10% Target Price239.52 Perf Year10.30%
Cash/sh10.44 P/C18.72 EPS next 5Y21.07% ROE31.60% 52W Range145.12 - 242.37 Perf YTD5.89%
Dividend- P/FCF81.53 EPS past 5Y34.90% ROI15.20% 52W High-20.32% Beta0.99
Dividend %- Quick Ratio2.80 Sales past 5Y22.80% Gross Margin71.00% 52W Low33.08% ATR6.01
Employees3700 Current Ratio3.10 Sales Q/Q20.50% Oper. Margin27.60% RSI (14)38.19 Volatility2.73% 3.01%
OptionableYes Debt/Eq0.73 EPS Q/Q122.60% Profit Margin23.50% Rel Volume0.43 Prev Close195.45
ShortableYes LT Debt/Eq0.56 EarningsJul 21 AMC Payout0.00% Avg Volume1.45M Price193.13
Recom1.90 SMA20-4.42% SMA50-9.56% SMA200-3.16% Volume482,288 Change-1.19%
Aug-27-15Initiated Cantor Fitzgerald Buy
Aug-19-15Reiterated Mizuho Buy $240 → $250
Jul-22-15Reiterated Mizuho Buy $230 → $240
Jul-22-15Reiterated Canaccord Genuity Buy $275 → $250
May-21-15Upgrade Morgan Stanley Equal-Weight → Overweight $162 → $190
Apr-22-15Reiterated Mizuho Buy $220 → $230
Mar-10-15Initiated UBS Buy $240
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Sep-04-15 12:16PM  This Stock May be the Best Opportunity in Biotech
Sep-03-15 06:30AM  Illumina to Webcast Live Presentation at the Morgan Stanley Global Healthcare Conference Business Wire
Sep-02-15 02:50PM  Illumina Acquires GenoLogics, Boosts Genomic Sequencing
Sep-01-15 07:35AM  What Illumina Gets With GenoLogics Life Science Software
06:30AM  Illumina Completes Acquisition of GenoLogics Business Wire
Aug-28-15 04:34PM  Ambarella Leads 4 Top Stocks With Rising Estimates at Investor's Business Daily
Aug-27-15 12:41PM  Illumina (ILMN) Stock Initiated with a 'Buy' Rating at Cantor Fitzgerald at TheStreet
06:29AM  Coverage initiated on Illumina by Cantor Fitzgerald
Aug-26-15 03:40PM  Becton, Dickinson: Cellular Research Buy Adds to Genomics
Aug-24-15 09:00PM  Burning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology Business Wire
05:54PM  LabCorp Reaching Past Doctor's Office To The Patient at Investor's Business Daily
09:25AM  RainDance pulls IPO citing market conditions at MarketWatch
Aug-20-15 02:30PM  Illumina (ILMN) Creates Helix to Encourage Genomics Startups
Aug-19-15 04:46PM  Google Gets YouTube Upgrade, Analog Devices PT Hiked at Investor's Business Daily
09:44AM  Illumina Creates Helix: Here's What It Is, And What It's Worth
Aug-18-15 05:41PM  Illumina Launches New Consumer-Genomics Startup at Investor's Business Daily
02:05PM  Gene-sequencing tech provider Illumina secures investors to create $100 million gene-sequencing venture Helix at
09:43AM  Illumina, Warburg Pincus Form Genetic-Testing Startup Helix at Bloomberg
03:01AM  Illumina partners with private equity firm on gene JV -sources Reuters
03:00AM  Illumina, Warburg Pincus, and Sutter Hill Ventures Form Helix to Accelerate Consumer Adoption of Genomics Business Wire
Aug-16-15 09:01AM  Billionaire Mandel Goes All-In On These Three Holdings at Insider Monkey
Aug-14-15 01:02PM  Short Sellers Wary Of Biotech Stocks
Aug-12-15 07:35AM  5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains at 24/7 Wall St.
Aug-09-15 09:02AM  3 Biotech Stocks to Buy in August at Motley Fool
Aug-06-15 01:04PM  ILLUMINA INC Financials
Aug-05-15 06:30AM  Illumina Accelerator Invests in Second Class of Genomics Startups from US and Europe Business Wire
Aug-04-15 04:05PM  Illumina Signs Agreement to Acquire GenoLogics, Leader in Genomics Laboratory Information Management System Market Business Wire
07:58AM  Gilead Sciences, Inc. Earnings Analysis: By the Numbers Q2*, 2015
Aug-03-15 08:09PM  10-Q for Illumina, Inc. at Company Spotlight
06:48PM  Big Cap Leaders Sail Past Earnings Season at Investor's Business Daily
Jul-31-15 04:31PM  ILLUMINA INC Files SEC form 10-Q, Quarterly Report
Jul-30-15 09:07AM  Large-Cap Healthcare Stocks Outperform Small Caps
09:01AM  Cramer on 2015's mixed signals
08:53AM  Celgene Corp. Earnings Analysis: By the Numbers
Jul-28-15 04:09PM  4 IBD 50 Stocks Poised To Bounce Back With Market
Jul-27-15 10:42AM  3 Signs That the Healthcare Stock Bubble Might Have Just Popped at Motley Fool
09:18AM  Illumina, Inc. Earnings Analysis: By the Numbers
Jul-24-15 07:14PM  Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market at Investor's Business Daily
Jul-22-15 08:08PM  Stock Market Today - 07/22/15 -8.44%
08:04PM  Biotech ETFs: 3 Questions For IShares Investing Expert at Investor's Business Daily
07:01PM  Why Earnings Season Should Matter To ETF Investors at Investor's Business Daily
04:50PM  Illumina Breaches Key Level On Q2 Sales Miss
02:54PM  Apple and 3 Other Stocks with Major Price Changes Post-Earnings - Stocks in the News
02:40PM  How to Trade 5 of the Market's Most Active Stocks at TheStreet
02:00PM  Illumina Gets a Reset
12:22PM  Edited Transcript of ILMN earnings conference call or presentation 21-Jul-15 9:00pm GMT
11:58AM  Why Illumina Inc. Stock Sank Like a Stone Today at Motley Fool
11:33AM  Illumina (ILMN) Stock Falls After Reporting Earnings Results at TheStreet
10:10AM  Illumina Tops Q2 Earnings, Misses on Revenues; EPS View Up - Analyst Blog
09:14AM  Linear Tech Misses Street 4Q Forecasts
08:39AM  Illumina (ILMN) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
08:31AM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition
08:02AM  Morning Movers: Biogen Tumbles on Trial Data; Coca-Cola, Boeing Gain on Earnings at
Jul-21-15 06:58PM  Illumina Stock Dives As Q2 Earnings Beat, Sales Miss at Investor's Business Daily
06:07PM  Key Takeaways from Ilumina's (ILMN) Q2 Earnings - Stocks in the News
06:03PM  Illumina Inc.'s Q2 Results Fall Short at Motley Fool
05:09PM  Illumina Falls as Second-Quarter Revenue Misses Expectations at Bloomberg
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today
04:24PM  Illumina beats 2Q profit forecasts
04:09PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Illumina Reports Financial Results for Second Quarter of Fiscal Year 2015 Business Wire
02:44PM  This stock hits health-care IT's sweet spot: Trader at CNBC
08:00AM  GenoLogics Releases Clarity LIMS X as Part of Illumina SeqLab Business Wire
07:07AM  Q2 2015 Illumina Inc Earnings Release - After Market Close
Jul-20-15 04:05PM  Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics Business Wire
09:35AM  Top Health Care Earnings for the Week Ahead at 24/7 Wall St.
Jul-18-15 09:06AM  3 Stocks to Take Advantage of the Rise in Personalized Medicine at Motley Fool
08:02AM  Move Aside Apple: 8 IBD 50 Stocks With Earnings Due at Investor's Business Daily
Jul-17-15 04:44PM  Illumina (ILMN) Stock Gained on Coverage Initiation at Canaccord at TheStreet
02:15PM  Can Illumina (ILMN) Continue its Earnings Streak in Q2? - Analyst Blog
08:51AM  Why Earnings Season Could Be Great for Illumina (ILMN) - Tale of the Tape
Jul-16-15 06:30AM  Illumina Introduces Illumina SeqLab Business Wire
Jul-14-15 06:38PM  As Biotech Beats, 6 Top ETF Picks For Rest Of 2015 at Investor's Business Daily
12:20AM  Prenatal Blood Tests Could Detect Cancer in Mothers at The Wall Street Journal
Jul-13-15 04:52PM  Prenatal Blood Tests Could Detect Cancer in Mothers at The Wall Street Journal
04:05PM  Study of Illuminas Non-Invasive verifiĀ® Prenatal Test Suggests that Test Results, When Discordant from Fetal Karyotyping, May Reflect Presence of Maternal Cancer Business Wire
Jul-10-15 10:12AM  Technology world imperfect: Nasdaq CEO
08:35AM  Why Illumina (ILMN) Could Beat Earnings Estimates Again - Tale of the Tape
Jul-08-15 01:45PM  Neogen, Illumina Extend Strategic Alliance in Agrigenomics - Analyst Blog
Jul-07-15 08:45AM  Neogen signs commercialization agreement with Illumina PR Newswire
06:30AM  Illumina to Announce Second Quarter 2015 Financial Results on Tuesday, July 21, 2015 Business Wire
Jul-02-15 11:16AM  Why Illumina The "Marvel" May See a Stock Rise
Jul-01-15 01:29PM  Robbins Arroyo LLP Is Investigating the Officers and Directors of Illumina, Inc. (ILMN) on Behalf of Shareholders PR Newswire
Jun-27-15 06:02PM  Biotech Short-Sellers Prefer Amgen To Gilead Sciences
Jun-26-15 01:30PM  BioMed Realty Signs Build-To-Suit Deal With Illumina in UK - Analyst Blog
Jun-25-15 05:29PM  Illumina, A Gene Research Leader, In Buy Range at Investor's Business Daily
09:31AM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement
09:17AM  BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster PR Newswire
Jun-23-15 03:40PM  IBD 50 Stocks Illumina, Avago Tech In Buy Range
02:32PM  Illumina Leads In Medicine's Next Frontier: Genetics at Investor's Business Daily
Jun-22-15 06:35PM  Top Stock INC Up 6 Weeks In Row, Just Out Of Buy Zone at Investor's Business Daily
Jun-17-15 06:52PM  Why Agilent Technologies is a "Hold"
Jun-16-15 03:30PM  San Diego-Based Illumina Inc's Stock Is Overvalued
Jun-15-15 01:47PM  Should Active Managers Blame the Benchmark? at
Jun-12-15 01:27PM  The Intro Guide to Illumina (ILMN): Inside the DNA Sequencing Leader - Stocks in the News
Jun-11-15 06:26AM  Edited Transcript of ILMN presentation 10-Jun-15 5:00pm GMT
Jun-10-15 03:00AM  Annoroad and Illumina to Co-Develop NGS Diagnostic System for Reproductive Health Business Wire
Jun-09-15 07:00PM  IBD Market Wrap - 06/09/15
05:38PM  Illumina Breaks Out To New High On Solid Volume at Investor's Business Daily
12:27PM  4 Stock Picks: Firms That Dominate Their Industries at
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. It has a collaboration agreement with Merck Serono to develop a sequencing-based oncology diagnostic; and Burning Rock to develop molecular diagnostics for oncology. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WALT DAVID RDirectorSep 01Sale195.082,000390,15142,960Sep 01 05:44 PM
FLATLEY JAY TChief Executive OfficerAug 27Option Exercise27.9725,000699,250449,996Aug 31 06:01 PM
Dadswell CharlesSr VP & General CounselAug 27Sale198.8116332,40641,162Aug 31 05:34 PM
FLATLEY JAY TChief Executive OfficerAug 27Sale200.1625,0005,004,125424,996Aug 31 06:01 PM
WALT DAVID RDirectorAug 18Sale206.892,000413,78544,960Aug 19 06:55 PM
BRADBURY DANIELDirectorAug 17Option Exercise75.661,700128,62216,076Aug 19 06:44 PM
BRADBURY DANIELDirectorAug 17Sale208.141,700353,84414,376Aug 19 06:44 PM
FLATLEY JAY TChief Executive OfficerAug 13Option Exercise27.9725,000699,250449,996Aug 13 06:51 PM
FLATLEY JAY TChief Executive OfficerAug 13Sale207.8525,0005,196,268424,996Aug 13 06:51 PM
Bouchard MichelChief Accounting OfficerAug 12Sale205.001,408288,64015,000Aug 13 06:03 PM
WALT DAVID RDirectorAug 11Sale208.695,4971,147,187648,840Aug 12 07:05 PM
EPSTEIN ROBERT SDirectorAug 10Option Exercise51.172,000102,3409,935Aug 12 06:46 PM
EPSTEIN ROBERT SDirectorAug 10Sale212.092,000424,1807,935Aug 12 06:46 PM
WALT DAVID RDirectorAug 04Sale215.0310,0002,150,322654,337Aug 06 05:37 PM
WALT DAVID RDirectorAug 04Sale214.992,000429,98746,960Aug 06 05:37 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 29Option Exercise50.943,510178,78347,673Jul 31 05:29 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 29Sale217.933,510764,93445,673Jul 31 05:29 PM
WALT DAVID RDirectorJul 28Sale217.2910,0002,172,879664,337Jul 29 08:52 PM
Dadswell CharlesSr VP & General CounselJul 27Sale218.9216736,56041,325Jul 29 08:29 PM
BOWMAN A BLAINEDirectorJul 24Option Exercise39.143,000117,42016,615Jul 24 07:35 PM
BOWMAN A BLAINEDirectorJul 24Sale221.473,000664,40813,615Jul 24 07:35 PM
FLATLEY JAY TChief Executive OfficerJul 23Option Exercise27.9725,000699,250449,996Jul 24 07:19 PM
FLATLEY JAY TChief Executive OfficerJul 23Sale214.8725,0005,371,715424,996Jul 24 07:19 PM
WALT DAVID RDirectorJul 21Sale235.2410,0002,352,449674,337Jul 23 08:34 PM
WALT DAVID RDirectorJul 21Sale235.232,000470,46148,960Jul 23 08:34 PM
Ronaghi MostafaSr VP & CTOJul 17Sale235.001,200282,00041,856Jul 21 08:57 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 16Sale229.931,639376,85121,332Jul 17 06:29 PM
Ronaghi MostafaSr VP & CTOJul 15Sale231.581,000231,58042,056Jul 16 06:44 PM
Naclerio NicholasSr VP, Corporate DevelopmentJul 15Sale229.436,5911,512,20521,686Jul 17 05:19 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJul 15Sale229.483,751860,76222,971Jul 17 06:29 PM
WALT DAVID RDirectorJul 14Sale227.3910,0002,273,943684,337Jul 16 06:30 PM
Ronaghi MostafaSr VP & CTOJul 14Sale225.002,000450,00043,056Jul 16 06:44 PM
Stapley MarcSr VP & CFOJul 13Option Exercise36.302,40087,12020,298Jul 14 09:03 PM
Bouchard MichelChief Accounting OfficerJul 13Sale222.751,400311,85016,408Jul 14 08:41 PM
Stapley MarcSr VP & CFOJul 13Sale214.903,000644,70117,298Jul 14 09:03 PM
EPSTEIN ROBERT SDirectorJul 10Option Exercise51.172,000102,3409,935Jul 14 08:28 PM
EPSTEIN ROBERT SDirectorJul 10Sale219.812,000439,6207,935Jul 14 08:28 PM
OSTADAN OMEADSr VP Product Dev & OperationsJul 10Sale219.811,110243,98945,673Jul 14 08:05 PM
FLATLEY JAY TChief Executive OfficerJul 09Option Exercise27.9725,000699,250449,996Jul 10 05:10 PM
FLATLEY JAY TChief Executive OfficerJul 09Sale218.1025,0005,452,477424,996Jul 10 05:10 PM
WALT DAVID RDirectorJul 07Sale220.2210,0002,202,178694,337Jul 08 08:00 PM
WALT DAVID RDirectorJul 07Sale220.162,000440,32950,960Jul 08 08:00 PM
BRADBURY DANIELDirectorJul 06Option Exercise75.661,700128,62216,076Jul 07 02:03 PM
WHITFIELD ROY ADirectorJul 06Option Exercise39.144,500176,13018,148Jul 07 06:10 PM
BRADBURY DANIELDirectorJul 06Sale219.701,700373,48814,376Jul 07 02:03 PM
WHITFIELD ROY ADirectorJul 06Sale218.114,500981,47813,648Jul 07 06:10 PM
WALT DAVID RDirectorJun 30Sale217.6410,0002,176,449704,337Jun 30 05:56 PM
Dadswell CharlesSr VP & General CounselJun 29Sale215.6316034,50142,662Jun 29 06:30 PM
FLATLEY JAY TChief Executive OfficerJun 25Option Exercise32.6325,000815,750449,996Jun 26 04:28 PM
FLATLEY JAY TChief Executive OfficerJun 25Sale220.3425,0005,508,403424,996Jun 26 04:28 PM
BRADBURY DANIELDirectorJun 24Option Exercise75.661,700128,62216,076Jun 24 06:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 24Sale221.075,0841,123,90926,722Jun 24 05:25 PM
BRADBURY DANIELDirectorJun 24Sale221.231,700376,09814,376Jun 24 06:28 PM
WALT DAVID RDirectorJun 23Sale220.0910,0002,200,942714,337Jun 24 05:01 PM
WALT DAVID RDirectorJun 23Sale220.172,000440,33152,960Jun 24 05:01 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 17Sale215.713,751809,11231,806Jun 18 11:38 AM
WALT DAVID RDirectorJun 16Sale215.1410,0002,151,374724,337Jun 18 11:34 AM
Naclerio NicholasSr VP, Corporate DevelopmentJun 15Sale214.336,5901,412,45528,277Jun 15 07:49 PM
Bianchi Paul LSr. VP, Human ResourcesJun 15Sale215.833,408735,54961,123Jun 15 07:53 PM
Stapley MarcSr VP & CFOJun 12Option Exercise36.302,40087,12020,898Jun 15 07:38 PM
Bouchard MichelChief Accounting OfficerJun 12Sale216.111,400302,55415,008Jun 15 07:05 PM
Stapley MarcSr VP & CFOJun 12Sale214.903,000644,70117,898Jun 15 07:38 PM
FLATLEY JAY TChief Executive OfficerJun 11Option Exercise33.8025,000844,875449,996Jun 12 09:49 PM
FLATLEY JAY TChief Executive OfficerJun 11Sale216.4125,0005,410,350424,996Jun 12 09:49 PM
EPSTEIN ROBERT SDirectorJun 10Option Exercise51.172,000102,34011,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Option Exercise69.3410,000693,40045,557Jun 11 06:28 PM
EPSTEIN ROBERT SDirectorJun 10Sale214.242,000428,4809,460Jun 11 05:12 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficJun 10Sale214.9410,0002,149,41435,557Jun 11 06:28 PM
WALT DAVID RDirectorJun 09Sale213.4810,0002,134,778734,337Jun 11 09:15 PM
WALT DAVID RDirectorJun 09Sale213.642,000427,28554,960Jun 11 09:15 PM
WHITFIELD ROY ADirectorJun 05Option Exercise39.144,500176,13018,148Jun 08 02:41 PM
WHITFIELD ROY ADirectorJun 05Sale207.494,500933,70513,648Jun 08 02:41 PM
OSTADAN OMEADSr VP Product Dev & OperationsJun 04Sale206.25874180,26346,783Jun 05 08:06 PM
WALT DAVID RDirectorJun 02Sale204.4210,0002,044,150744,337Jun 04 07:18 PM
EASTHAM KARINDirectorJun 01Option Exercise39.145,000195,70015,419Jun 03 07:47 PM
EASTHAM KARINDirectorJun 01Sale205.245,0001,026,21611Jun 03 07:47 PM
BRADBURY DANIELDirectorMay 29Option Exercise75.661,700128,62216,076Jun 01 07:24 PM
BRADBURY DANIELDirectorMay 29Sale206.621,700351,25414,376Jun 01 07:24 PM
FLATLEY JAY TChief Executive OfficerMay 28Option Exercise33.8025,000844,875449,996May 29 07:05 PM
FLATLEY JAY TChief Executive OfficerMay 28Sale208.7825,0005,219,502424,996May 29 07:05 PM
Dadswell CharlesSr VP & General CounselMay 27Sale206.6217035,12541,652May 28 08:04 PM
WALT DAVID RDirectorMay 26Sale204.7410,0002,047,382752,427May 28 07:26 PM
WALT DAVID RDirectorMay 26Sale204.792,000409,58356,960May 28 07:26 PM
BOWMAN A BLAINEDirectorMay 22Option Exercise39.143,000117,42015,722May 26 08:25 PM
BOWMAN A BLAINEDirectorMay 22Sale204.583,000613,74812,722May 26 08:25 PM
WALT DAVID RDirectorMay 19Sale202.0010,0002,020,042762,427May 19 06:07 PM
Naclerio NicholasSr VP, Corporate DevelopmentMay 15Sale199.166,5901,312,48734,867May 19 05:31 PM
FLATLEY JAY TChief Executive OfficerMay 14Option Exercise33.8025,000844,875449,996May 15 09:06 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 14Sale198.523,751744,64035,557May 15 08:55 PM
FLATLEY JAY TChief Executive OfficerMay 14Sale197.7625,0004,944,122424,996May 15 09:06 PM
Bianchi Paul LSr. VP, Human ResourcesMay 13Sale197.143,356661,60264,531May 14 07:14 PM
Stapley MarcSr VP & CFOMay 12Option Exercise36.302,40087,12021,498May 14 08:10 PM
WALT DAVID RDirectorMay 12Sale196.205,000981,020772,427May 14 07:07 PM
WALT DAVID RDirectorMay 12Sale196.292,000392,58058,960May 14 07:07 PM
Bouchard MichelChief Accounting OfficerMay 12Sale195.721,400274,00819,208May 14 07:28 PM
Stapley MarcSr VP & CFOMay 12Sale196.163,000588,46618,498May 14 08:10 PM
EPSTEIN ROBERT SDirectorMay 11Option Exercise51.172,000102,3409,042May 12 09:28 PM
EPSTEIN ROBERT SDirectorMay 11Sale196.492,000392,9807,042May 12 09:28 PM
HENRY CHRISTIAN OSr VP & Chief Commercial OfficMay 05Option Exercise69.3411,500797,41050,808May 07 06:29 PM
WHITFIELD ROY ADirectorMay 05Option Exercise39.144,500176,13016,238May 07 06:58 PM